Cardinal Point Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5M Sell
72,763
-1,280
-2% -$298K 1.05% 26
2026
Q1
$18.1M Sell
74,043
-2,342
-3% -$546K 1.11% 24
2025
Q4
$15.8M Buy
76,385
+728
+1% +$144K 1.03% 25
2025
Q3
$14M Sell
75,657
-77,027
-50% -$13.2M 0.98% 26
2025
Q2
$23.2M Buy
152,684
+76,087
+99% +$11.7M 1.84% 13
2025
Q1
$12.7M Buy
+76,597
New +$12M 1.16% 25
2023
Q1
Sell
-1,337
Closed -$236K 82
2022
Q4
$236K Buy
+1,337
New +$231K 0.08% 63

Other funds holding JNJ

Cardinal Point Capital Management's JNJ Position: Q2 2026 in Review

Cardinal Point Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $298K and leaving 72,763 shares worth $18.5M. The position accounts for 1.05% of the portfolio, ranked #26.

Cardinal Point Capital Management first reported a position in JNJ in Q4 2022 and has held it in 7 quarters since. The position peaked at $23.2M in Q2 2025. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cardinal Point Capital Management held 72,763 shares of Johnson & Johnson worth $18.5M as of Q2 2026.
  • Cardinal Point Capital Management sold 1,280 Johnson & Johnson shares in Q2 2026, an estimated $298K.
  • Johnson & Johnson made up 1.05% of Cardinal Point Capital Management's portfolio in Q2 2026, its #26 holding.
  • Cardinal Point Capital Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 7 quarters since.
  • Cardinal Point Capital Management's Johnson & Johnson position peaked at $23.2M in Q2 2025.
  • 1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cardinal Point Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.